Extreme heterogeneity of myeloablative total body irradiation techniques in clinical practice: A survey of the acute leukemia working party of the european group for blood and marrow transplantation

Cancer

Volumn 120, Issue 17, 2014, Pages 2760-2765

  Giebel, Sebastian ^a   Miszczyk, Leszek ^a   Slosarek, Krzysztof ^a   Moukhtari, Leila ^b   Ciceri, Fabio ^c   Esteve, Jordi ^d   Gorin, Norbert Claude ^b,e,f   Labopin, Myriam ^b,e,f   Nagler, Arnon ^g   Schmid, Christoph ^h   Mohty, Mohamad ^b,e,f  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b HÔPITAL SAINT ANTOINE   (France)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d HOSPITAL CLÍNIC   (Spain)

^e SORBONNE UNIVERSITÉ   (France)

^f CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^g SHEBA MEDICAL CENTER   (Israel)

^h UNIVERSITY OF MUNICH   (Germany)

Author keywords

hematopoietic stem cell transplantation; radiation dosimetry; radiotherapy dose; radiotherapy fractionation; total body irradiation

Indexed keywords

ARTICLE; CLINICAL PRACTICE; DOSIMETRY; HUMAN; IN VIVO STUDY; LUNG; MYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RADIATION BEAM; RADIATION DOSE FRACTIONATION; RADIATION FIELD; RADIATION SAFETY; RADIATION SHIELD; TREATMENT DURATION; WHOLE BODY RADIATION;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; RADIATION DOSIMETRY; RADIOTHERAPY DOSE; RADIOTHERAPY FRACTIONATION; TOTAL BODY IRRADIATION;

DOSE FRACTIONATION; EUROPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; RADIOMETRY; TRANSPLANTATION CONDITIONING; WHOLE-BODY IRRADIATION;

EID: 84906342640     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28768     Document Type: Article

References (29)

1. Thomas ED, Buckner CD, Banaji M, et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood. 1977; 49: 511-533.
2. Thomas ED, Buckner CD, Clift RA, et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med. 1979; 301: 597-599.
3. Clift RA, Buckner CD, Appelbaum FR, et al. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood. 1990; 76: 1867-1871.
4. Clift RA, Buckner CD, Appelbaum FR, et al. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens. Blood. 1991; 77: 1660-1665.
5. Santos GW, Tutschka PJ, Brookmeyer R, et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med. 1983; 309: 1347-1353.
6. Tutschka PJ, Copelan EA, Klein JP,. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood. 1987; 70: 1382-1388.
7. Gupta T, Kannan S, Dantkale V, Laskar S,. Cyclophosphamide plus total body irradiation compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation in patients with leukemia: a systematic review and meta-analysis. Hematol Oncol Stem Cell Ther. 2011; 4: 17-29.
8. Buchali A, Feyer P, Groll J, et al. Immediate toxicity during fractionated total body irradiation as conditioning for bone marrow transplantation. Radiother Oncol. 2000; 54: 157-162.
9. Leiper AD,. Late effects of total body irradiation. Arch Dis Child. 1995; 72: 382-385.
10. Socie G, Salooja N, Cohen A, et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood. 2003; 101: 3373-3385.
11. Deeg HJ, Socie G,. Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood. 1998; 91: 1833-1844.
12. Thomas ED, Lochte HL Jr, Cannon JH, et al. Supralethal whole body irradiation and isologous marrow transplantation in man. J Clin Invest. 1959; 38: 1709-1716.
13. Quast U,. Total body irradiation-review of treatment techniques in Europe. Radiother Oncol. 1987; 9: 91-106.
14. Quast U,. Whole body radiotherapy: a TBI-guideline. J Med Phys. 2006; 31: 5-12.
15. Wolden SL, Rabinovitch RA, Bittner NH, et al. American College of Radiology; American Society for Radiation Oncology. American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) practice guideline for the performance of total body irradiation (TBI). Am J Clin Oncol. 2013; 36: 97-101.
16. Adkins DR, DiPersio JF,. Total body irradiation before an allogeneic stem cell transplantation: is there a magic dose? Curr Opin Hematol. 2008; 15: 555-560.
17. Appelbaum FR,. The influence of total dose, fractionation, dose rate, and distribution of total body irradiation on bone marrow transplantation. Semin Oncol. 1993; 20 (suppl 4): 3-10.
18. Thomas ED, Clift RA, Hersman J, et al. Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation. Int J Radiat Oncol Biol Phys. 1982; 8: 817-821.
19. Deeg HJ, Sullivan KM, Buckner CD, et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation. Bone Marrow Transplant. 1986; 1: 151-157.
20. Girinsky T, Benhamou E, Bourhis JH, et al. Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies. J Clin Oncol. 2000; 18: 981-986.
21. Ozsahin M, Pene F, Touboul E, et al. Total-body irradiation before bone marrow transplantation. Results of two randomized instantaneous dose rates in 157 patients. Cancer. 1992; 69: 2853-2865.
22. Cheng JC, Schultheiss TE, Wong JY,. Impact of drug therapy, radiation dose, and dose rate on renal toxicity following bone marrow transplantation. Int J Radiat Oncol Biol Phys. 2008; 71: 1436-1443.
23. Thomas O, Mahe M, Campion L, et al. Long-term complications of total body irradiation in adults. Int J Radiat Oncol Biol Phys. 2001; 49: 125-131.
24. Gruen A, Ebell W, Wlodarczyk W, et al. Total body irradiation (TBI) using helical tomotherapy in children and young adults undergoing stem cell transplantation. Radiat Oncol. 2013; 8: 92.
25. Yorke E, Gelblum D, Ford E,. Patient safety in external beam radiation therapy. AJR Am J Roentgenol. 2011; 196: 768-772.
26. Soule BP, Simone NL, Savani BN, et al. Pulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplant. Bone Marrow Transplant. 2007; 40: 573-578.
27. Singh AK, Karimpour SE, Savani BN, et al. Pretransplant pulmonary function tests predict risk of mortality following fractionated total body irradiation and allogeneic peripheral blood stem cell transplant. Int J Radiat Oncol Biol Phys. 2006; 66: 520-527.
28. Deeg HJ, Flournoy N, Sullivan KM, et al. Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. Int J Radiat Oncol Biol Phys. 1984; 10: 957-964.
29. Ozsahin M, Belkacemi Y, Pene F, et al. Total-body irradiation and cataract incidence: a randomized comparison of two instantaneous dose rates. Int J Radiat Oncol Biol Phys. 1994; 28: 343-347.